1-4 of 4
Jason Smith
Close
Sort by
Journal Articles

Pharmacogenetic Approaches Identify ANTXR1 As a Potential Mediator of Response to Therapeutic NF-κB Inhibition in Diffuse Large B Cell Lymphoma

Soham D. Puvvada, MD, Cassandra L Love, Vladimir Grubor, PhD, Jenny Zhang, Jason Smith, Sandeep S. Dave, MD
Journal: Blood
Blood (2011) 118 (21): 234.
https://doi.org/10.1182/blood.V118.21.234.234
Published: 2011
Journal Articles

Hedgehog Pathway Inhibition Is a Novel Therapeutic Approach in Lymphomas and Its Efficacy is Inversely Related to PI3 Kinase Inhibition

Katherine J. Walsh, MD, Siyao Fan, Amee Patel, Cassandra L Jacobs, MS, Jason Smith, Qingquan Liu, PhD, Sandeep Dave, MD
Journal: Blood
Blood (2010) 116 (21): 1848.
https://doi.org/10.1182/blood.V116.21.1848.1848
Published: 2010
Journal Articles

Selective IKKβ Inhibition of the NF-Kappab Pathway Is An Effective Therapeutic Strategy In Lymphomas

Soham D. Puvvada, MD, Jason Smith, Cassandra L Jacobs, MS, Sandeep Dave, MD
Journal: Blood
Blood (2010) 116 (21): 1849.
https://doi.org/10.1182/blood.V116.21.1849.1849
Published: 2010
Journal Articles

Upregulated JAK/STAT Signaling Represents a Major Mode of Resistance to HDAC Inhibition In Lymphoma and Provides a Rationale for Novel Combination Therapy

Jason Smith, Katherine J. Walsh, MD, Cassandra L Jacobs, MS, Qingquan Liu, PhD, Siyao Fan, Amee Patel, Sandeep Dave, MD
Journal: Blood
Blood (2010) 116 (21): 434.
https://doi.org/10.1182/blood.V116.21.434.434
Published: 2010